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Abstract 
Background: Recently, involvement of IL‑19, IL‑20 and IL‑24 has been reported in inflammatory diseases associated 
with tissue remodeling. However, their impact on the pathomechanism of coeliac disease (CD) is still completely 
unknown.
Methods: Expression of IL19, IL20 and IL24 was measured by real‑time RT‑PCR, protein amount of IL‑24, α smooth 
muscle actin (α‑SMA) and fibronectin (FN) was determined by Western‑blot analysis in the duodenal biopsies of 
therapy naive children with CD and controls. Localization of IL‑24 and IL‑20RB was investigated by immunofluorescent 
staining in the duodenal mucosa. Effect of recombinant IL‑1β, TNF‑α, TGF‑β and IL‑17 treatment on the expression of 
IL19, IL20, IL24 and their receptors was investigated by real‑time RT‑PCR in small intestinal epithelial cells (FHs74Int), in 
primary duodenal myofibroblasts (pdMFs) and in peripheral blood mononuclear cells (PBMCs). Effect of IL‑24 on  H2O2 
treated FHs74Int cells and on pdMFs was measured by MTT, LDH, Annexin V assays, real‑time RT‑PCR and by fluores‑
cent microscopy.
Results: We found increased level of IL‑24 (3.3×, p < 0.05), α‑SMA (2.4×, p < 0.05) and FN (2.3×, p < 0.05) in the duo‑
denal mucosa and increased expression of IL19 (3.6×, p < 0.05) and IL24 (5.2×, p < 0.05) in the PBMCs of children with 
CD compared to that of controls. IL‑1β was a strong inducer of IL24 expression of FHs74Int cells (9.9×, p < 0.05), pdMFs 
(552.9×, p < 0.05) or PBMCs (17.2×, p < 0.05), as well. IL‑24 treatment reduced the number of apoptotic cells (0.5×, 
p < 0.05) and decreased the expression of inflammatory factors, including IL1A, IL6 and TNF of  H2O2‑treated FHs74Int 
cells. IL‑24 decreased the proliferation (0.6×, p < 0.05) of PDGF‑B treated pdMFs. Moreover, IL‑24 treatment altered the 
morphology of pdMFs by influencing the size of the angles between stress fibers and the longitudinal axis of the cells 
(2.0×, p < 0.05) and the expression of cytoskeletal components, including ACTA2, ACTB, VIM, SNAI1 and SNAI2.
Conclusion: Our results suggest that IL‑24 plays a significant role in the maintenance of duodenal mucosal integrity 
in CD.
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Introduction
Coeliac disease (CD) is a chronic, autoimmune enter-
opathy caused by exposure to dietary gluten in geneti-
cally susceptible individuals [1]. CD is highly prevalent, 
it affects approximately 1% of the population worldwide 
[2]. Currently, the therapy of CD is limited to the strict 
life-long gluten free diet (GFD). However, the high num-
ber of patients with non-responsive CD and also the sig-
nificant therapeutic burden of GFD necessitate the better 
understanding the pathomechanism of the disease.
The interleukin (IL)-20 subfamily of cytokines is part 
of the IL-10 family and comprises five related molecules, 
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including IL-19, IL-20, IL-22, IL-24 and IL-26 [3]. The 
best-known function of the subfamily is to establish a link 
between leukocytes and epithelial cells, thereby enhanc-
ing innate defence mechanism and repairing processes 
at the epithelial surfaces [4]. These cytokines are mainly 
produced by immune cells [5, 6], however, other cell 
types, such as epithelial cells or myofibroblasts (MFs) can 
also release them [7, 8]. IL-19, IL-20 and IL-24 form a 
separate group within the subfamily, as they use the com-
mon IL-20RA/IL-20RB and IL-22RA/IL-20RB receptor 
heterodimers [9, 10].
Recently, increased expression of IL-19, IL-20 and 
IL-24 has been demonstrated in the colonic mucosa and 
also in peripheral blood mononuclear cells (PBMCs) of 
patients with inflammatory bowel diseases (IBD) [11–
15]. However, to the best of our knowledge, there are no 
previous data available about the significance of IL-19, 
IL-20 and IL-24 in CD.
In the present study, we hypothesized that cytokines of 
the IL-20 subfamily may influence the repair process of 
the chronically inflamed small intestinal mucosa. There-
fore, we examined the expression of IL-19, IL-20 and 
IL-24 and their receptors in duodenal biopsies of pedi-
atric patients with CD. In  vitro experiments were per-
formed to determine the effect of inflammatory cytokines 
on the expression of the investigated interleukins and 
their receptors. Finally, as duodenal epithelial cells and 
duodenal MFs play prominent role in the remodeling of 
injured mucosa, we examined the effect of IL-24 on these 
cell types.
Methods
Duodenal biopsies
Mucosal biopsies of therapy naive pediatric CD patients 
(n = 16, age: 6.75 ± 3.38 years) and controls (n = 14, age: 
12.71 ± 4.81  years) (Additional file  1) were collected at 
the 1st Department of Pediatrics, Semmelweis Univer-
sity, Hungary. Written informed consent was obtained 
from parents of each participant prior to the procedure 
and the study was approved by the Semmelweis Univer-
sity Regional and Institutional Committee of Science and 
Research Ethics (TUKEB 58/2013). CD was diagnosed 
based on the symptoms, serology (anti-tissue transglu-
taminase IgA and IgG) and duodenal histology (Marsh 
criteria), according to the criteria of the European Society 
for Pediatric Gastroenterology, Hepatology, and Nutri-
tion (ESPGHAN) [16]. Control subjects were referred 
with recurrent abdominal pain, growth retardation and 
diarrhoea and an upper gastrointestinal endoscopy was 
part of their diagnostic procedure. Biopsies were imme-
diately snap-frozen and stored at −  80  °C until further 
analysis.
Recombinant proteins applied for cell culture experiments
Recombinant human epidermal growth factor (EGF), 
tumor necrosis factor alpha (TNF-α), interleukin-17 (IL-
17), interleukin-24 (IL-24), and platelet-derived growth 
factor B (PDGF-B) were purchased from R&D Systems 
(Minneapolis, MN, USA). Recombinant human interleu-
kin-1 beta (IL-1β) and transforming growth factor beta-1 
(TGF-β) were purchased from Life Technologies (Carls-
bad, CA, USA). EGF, TNF-α, and IL-24 were dissolved 
in sterile phosphate buffered saline (PBS); IL-1β was dis-
solved in sterile distilled water; IL-17, TGF-β and PDGF-
B were dissolved in 4 mM HCl.
FHs74Int small intestinal epithelial cell culture
Human small intestinal epithelial cell line (FHs74Int), 
(American Type Culture Collection (ATCC), Manassas, 
VA, USA) was cultured in Hybri-Care Medium (ATCC) 
supplemented with 30 ng/mL EGF, 10% heat-inactivated 
fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA, 
USA) and 1% penicillin and streptomycin mixture (Life 
Technologies) under standard cell culture conditions 
(37 °C, humidified, 5%  CO2/95% air environment).
For real time RT-PCRs the cells were seeded into 6 
or 96 well plates at a density of  105 or  104 cells/well and 
treated with IL-1β (100  ng/mL), TNF-α (10  ng/mL), 
TGF-β (0.5  nM), or IL-17 (100  ng/mL) on 6 well plates 
(n = 6 well/treatment group), or with IL-24 (0.1  ng/mL) 
and  H2O2 (1000 µM) on 96 well plates (n = 5 well/treat-
ment group) for 24 h, respectively.
For MTT and LDH assays the cells were seeded into 
96-well plates at a density of  104 cells/well (n = 5 well/
treatment group) and treated with IL-24 (0.1 ng/mL) and 
 H2O2 (200, 400, 600, 800 or 1000  µM) (Sigma-Aldrich) 
for 24 h.
The cells were seeded into 6 well plates at a density 
of 3  ×  105 cells/well (n = 3 well/treatment group) for 
the Annexin V apoptosis assay, and treated with IL-24 
(0.1 ng/mL) and  H2O2 (1000 µM) for 48 h.
Vehicle treated cells served as controls in all 
experiments.
Primary duodenal myofibroblast cell culture (pdMFs)
PdMFs were freshly isolated from the duodenal mucosa 
of control children according to a method described pre-
viously [17]. PdMFs were cultured in Dulbecco’s Modi-
fied Eagle Medium (Invitrogen) supplemented with 1% 
FBS and 1% Penicillin and Streptomycin mixture under 
standard cell culture conditions (37  °C, humidified, 5% 
 CO2/95% air environment).
For real time RT-PCRs the pdMFs were seeded into 6 
or 96 well plates at a density of  105 or  104 cells/well and 
treated with IL-1β (100  ng/mL), TNF-α (10  ng/mL), 
TGF-β (0.5  nM), or IL-17 (100  ng/mL) on 6 well plates 
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(n = 6 well/treatment group), or with IL-24 (0.01 ng/mL) 
and PDGF-B (10  ng/mL) on 96 well plates (n = 5 well/
treatment group) for 24 h, respectively.
To investigate the orientation of α-SMA immuno-
positive stress fibers, pdMFs were seeded in 4-well cell 
culture chambers at a density of 2 ×  104 cells/well and 
treated with TGF-β (0.5 nM) or IL-24 (0.1 ng/mL) only, 
or co-treated with IL-24 (0.1 ng/mL) and TGF-β (0.5 nM) 
for 24 h. For MTT and LDH assays pdMFs were seeded 
into 96-well plates at a density of  104 cells/well (n = 5 
well/treatment group) and treated with IL-24 (0.01, 0.1, 
1, 10 or 100 ng/mL) and PDGF-B (10 ng/mL) for 24 h.
To perform Sirius Red assay, pdMFs were seeded into 
96-well plates at a density of  104 cells/well (n = 5 well/
treatment group), and treated with 0.01, 0.1, 1, 10 or 
100 ng/mL IL-24 and 0.5 nM TGF-β for 48 h.
Vehicle treated cells served as controls in all 
experiments.
Peripheral blood mononuclear cells (PBMCs)
In this experiment, 8 children with CD on gluten-
free diet (age: 10.86 ± 2.99  years) and 8 controls (age: 
10.30 ± 4.62  years) were enrolled. Control subjects had 
gastrointestinal symptoms, but during their gastroen-
terological examination CD was excluded. PBMCs were 
isolated by density gradient centrifugation using Histo-
paque-1077 (Sigma-Aldrich). After isolation, the cells 
were placed into RPMI 1640 medium (ATCC) supple-
mented with 10% FBS and 1% penicillin and streptomy-
cin mixture.
For real time RT-PCRs, PBMCs derived from CD 
patient were seeded into 24-well plates at a density of 
5  ×  105 cells/well (n = 6 well/treatment group) and 
treated either with IL-1β (100  ng/mL), TNF-α (10  ng/
mL), TGF-β (0.5 nM) or IL-17 (100 ng/mL) for 24 h.
Vehicle treated cells served as controls.
Immunohistochemistry
Frozen duodenal biopsy samples derived from controls 
and children with CD were embedded into Shandon cry-
omatrix (ThermoElectron Co., Madison, WI, USA) and 
cut into 5  μm sections. Samples were incubated with 
primary antibodies specific for human IL-24 (ab182567; 
rabbit, 1:100, Abcam, Cambridge, United Kingdom) 
or IL-20RB (ab124332; rabbit, 1:100, Abcam) for 1  h at 
room temperature (RT). After repeated washing, slides 
were incubated with the corresponding Alexa Fluor 568 
secondary antibody (1:200 anti-rabbit, Invitrogen) for 
30 min at RT in the dark and counterstained with Hoe-
chst 33342 (1:2000, Sigma-Aldrich). Finally, sections 
were coverslipped with Vectashield fluorescent mount-
ing medium (Vector Laboratories, Burlingame, Calif., 
USA). Appropriate controls were performed by omitting 
the primary antibody to assure specificity and to avoid 
autofluorescence. Sections were analyzed with a Nikon 
C2 confocal laser scanning microscope system (Nikon, 
Minato, Tokyo, Japan).
Immunocytochemistry
FHs74Int and MFs were seeded in chambers and cultured 
for 24 h in 37 °C. After repeated washing slides were per-
meabilized with Cytofix/Cytoperm (BD Pharmingen, San 
Diego, CA, USA) for 15  min at RT, then washed again, 
and incubated with primary antibody specific for IL-
20RB (ab124332; rabbit, 1:100, Abcam) or α-SMA (sc-
53015; mouse, 1:1000, Santa Cruz Biotechnology, Dallas, 
TX, USA) for 1 h at RT. Thereafter the slides were washed 
with WashPerm solution and incubated with the corre-
sponding Alexa Fluor 568 or 488 conjugated secondary 
antibody (1:200 anti-rabbit or anti-mouse, Invitrogen) for 
30 min (min) at RT in the dark and counterstained with 
Hoechst 33342 (1:2000, Sigma-Aldrich). Finally, slides 
were coverslipped with Vectashield fluorescent mount-
ing medium (Vector Laboratories). Appropriate controls 
were performed by omitting the primary antibodies to 
assure their specificity and to avoid autofluorescence. 
Sections were analyzed with a Nikon C2 confocal laser 
scanning microscope system (Nikon Corporation, Tokyo, 
Japan).
RNA isolation, reverse transcription and real‑time RT‑PCR
Total RNA was isolated from duodenal biopsy samples, 
FHs74Int cells, pdMFs or PBMCs by Geneaid Total RNA 
Mini Kit (Geneaid Biotech Ltd., New Taipei City, Tai-
wan). RNA (500  ng/sample) was reverse-transcribed 
using SuperScript III reverse transcriptase (Life Tech-
nologies) to generate first-stranded cDNA. The mRNA 
expression of the investigated genes was determined by 
real-time PCR using LightCycler 480 SYBR Green I Mas-
ter enzyme mix on a Light Cycler 480 system (Roche 
Diagnostics, Mannheim, Germany). The nucleotide 
sequences and annealing temperatures of the primer 
pairs and the resulted PCR product lengths are shown 
in Additional file 2 [18]. Relative mRNA expression was 
determined by comparison with RPLP0 as internal con-
trol using the ∆∆Ct method [19]. Data were normalized 
and presented as the ratio of their control values.
Protein isolation and Western blot analysis
Duodenal biopsy samples were homogenized in lysis 
buffer, containing 50 mM HEPES, 150 mM NaCl, 1% Tri-
ton X-100, 5 mM EDTA, 5 mM EGTA, 20 mM sodium 
pyrophosphate, 20  mM NaF, 0.2  mg/mL phenylmethyl-
sulfonyl fluoride, 0.01  mg/mL leupeptin, and 0.01  mg/
mL aprotinin (pH 7.4) (each substance was obtained 
from Sigma-Aldrich). Thereafter protein concentration 
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was determined by a detergent-compatible protein assay 
(Bio-Rad, Hercules, CA). Denatured samples [20] (20 μg 
protein/lane) were separated on 4-20% gradient SDS pol-
yacrylamide gel, and transferred to nitrocellulose mem-
branes. The nitrocellulose membranes were blocked with 
5% non-fat milk in tris-buffered saline (TBS) for 1  h at 
RT. Thereafter, they were incubated overnight at 4  °C 
with antibodies specific for human IL-24 (ab182567; 
1:1000, Abcam), α-SMA (sc-53015; 1:10,000, Santa Cruz 
Biotechnology), FN (ab2413; 1:2000, Abcam) or GAPDH 
(sc-47724; 1:2000, Santa Cruz Biotechnology). After 
repeated washing with TBS containing 0.05% Tween-20 
and 1% non-fat milk, membranes were incubated with 
the corresponding horseradish peroxidase-conjugated 
secondary antibodies (1:2000 anti-rabbit or anti-mouse, 
Santa Cruz Biotechnology) for 1 h at RT. Bands of interest 
were detected using enhanced chemiluminescence detec-
tion (Western Blotting Luminol Reagent, GE Health-
care, Waukesha, WI) and quantified by densitometry 
(VersaDoc, Quantity One Analysis software; Bio-Rad) as 
integrated optical density after background subtraction. 
Relative protein levels were determined by comparison 
with GAPDH as internal control. Data were normalized 
and presented as the ratio of control values.
MTT cell proliferation and viability assay
MTT cell proliferation and viability assay was per-
formed by using Cell Proliferation Kit I (Roche Diagnos-
tics) according to the manufacturer’s recommendations. 
Absorbance was recorded at 570  nm and at 690  nm as 
background using a Hidex Chameleon Microplate Reader 
(Triathler, Plate Chameleion, 300SL Lablogic Systems, 
Inc., Brandon, FL, USA) using MikroWin 2000 software.
LDH cytotoxicity assay
LDH assay was performed as previously described 
[21]. All reagents were purchased from Sigma-Aldrich. 
Absorbance was recorded at 570  nm and at 690  nm as 
background in a Hidex Chameleon Microplate Reader 
using MikroWin 2000 software.
Apoptosis detection assay
The apoptosis assay was performed using FITC Annexin 
V Apoptosis Detection Kit I (BD Pharmingen) accord-
ing to the manufacturer’s recommendations. Cells that 
are negative for Annexin V and PI are refered as viable 
cells, cells that are positive for Annexin V and negative 
for PI are refered as early apoptotic cells and cells that are 
positive for Annexin V and PI are referec as late apop-
totic cells. Necrotic cell debris are negative for Annexin V 
and positive for PI. The flow cytometry analysis was per-
formed using a FACS Aria cytometer (BD).
SiriusRed collagen detection assay
The SiriusRed assay was performed as previously 
described [22]. All reagents were purchased from Sigma-
Aldrich. Absorbance was determined at 544  nm and at 
690  nm as background using Hidex Chameleon Micro-
plate Reader using MikroWin 2000 software.
Graphical analysis of stress fiber orientation
Assessment of the orientation of α-SMA immunopositive 
stress fibers in pdMFs was carried out by graphical analy-
sis. Images of 35–40 randomly selected cells from each 
treatment group were taken using the Olympus IX81 
fluorescent microscope system (Olympus Corporation, 
Tokyo, Japan). To properly represent the whole-cell stress 
fiber network, the angle between at least 20 stress fib-
ers per cell and the long axis of MFs were determined by 
ImageJ 1.48v software (The National Institutes of Health, 
Bethesda, MD) [23]. The parallelism of stress fibers with 
the long axis was defined as the width of 95% confidence 
interval of the measured angels in each cell.
Statistical analysis
Statistical evaluation of data was performed by GraphPad 
Prism 6.01 software (GraphPad Software Inc., La Jolla, 
CA, USA). After testing normality with the Kolmogo-
rov–Smirnov test, raw data of real-time RT-PCR, West-
ern blot and stress fiber orientation measurements were 
analyzed with Mann–Whitney U-test or Kruskal–Wallis 
test to determine the differences between correspond-
ing groups. Multiple comparisons of the raw data derived 
from MTT, LDH, Annexin V apoptosis and SiriusRed 
assays were performed by using multiple t-test and ordi-
nary two-way ANOVA with Dunnett correction. p ≤ 0.05 
was considered as statistically significant. Values were 
expressed as mean + SD.
Results
Alteration of IL‑19, ‑20 and ‑24, IL‑20RB, α‑SMA and FN 
in the duodenal mucosa of children with CD
The mRNA expression of IL24 was increased in the duo-
denal mucosa of children with CD compared to that of 
controls (Fig. 1c). There was no difference in the mRNA 
expression of IL19 (Fig. 1a) between the groups, and the 
expression of IL20 (Fig.  1b) was undetectable. Protein 
amounts of IL-24, FN and α-SMA were elevated in the 
duodenal mucosa of children with CD compared to con-
trols (Fig.  1d–f). Strong IL-24 and IL-20RB immunore-
activity was observed in the duodenal crypt enterocytes 
of children with CD (Fig. 1i). IL-20RB immunopositivity 
was observed on FHs74Int intestinal epithelial cells and 
on pdMFs, as well (Fig. 1h).
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Fig. 1 Alteration of IL‑19, ‑20 and ‑24, IL‑20RB, α‑SMA and FN in the duodenal mucosa of children with CD. The mRNA expression of IL19 (a), IL20 
(b) and IL24 (c) of the duodenal mucosa of children with CD (n = 16) and controls (n = 14) was determined by real‑time RT‑PCR in comparison with 
RPLP0 as internal control. Relative protein amounts (and representative immunoblots) of IL‑24 (d, g), FN (e, g) and α‑SMA (f, g) of the duodenal 
mucosa of children with CD (n = 13) and controls (n = 11) were investigated by Western blot analysis in comparison with GAPDH as internal 
control (g). Results are presented as mean ± SD. *p < 0.05 vs. control (Mann–Whitney U‑test). Presence of IL‑20RB (red) in FHs74Int cells and 
pdMFs (h) and the localisation of IL‑24 (green) and IL‑20RB (red) in the duodenal mucosa of children with CD and controls (i) was determined by 
immunofluorescence staining. Cell nuclei were counterstained with Hoechst 33342 (blue). Magnified regions are highlighted by white squares. 
Scale bar: 100 µm and 50 µm
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Effect of IL‑1β, TNF‑α, TGF‑β and IL‑17 treatment 
on the expression of IL‑19, ‑20, ‑24 and their receptors
In FHs74Int cells IL-1β treatment increased, TNF-α and 
IL-17 treatment decreased the mRNA expression of IL19, 
IL20 and IL24 (Fig.  2a, Additional file  3). TGF-β treat-
ment increased the mRNA expression of IL20. TGF-β 
and TNF-α treatment decreased the mRNA expression of 
IL20RA. IL-1β or TGF-β treatment increased the mRNA 
expression of IL20RB and decreased that of IL22RA. 
IL-17 treatment decreased the expression of IL22RA in 
FHs74Int cells (Fig. 2a, Additional file 4).
In pdMFs IL-1β and TNF-α treatment increased the 
mRNA expression of IL19, IL20 and IL24, and TGF-β 
treatment increased the mRNA expression of IL20 
(Fig.  2b, Additional file  5). IL-1β, TNF-α, and TGF-β 
treatment decreased the expression of IL20RA and 
increased that of IL20RB. The mRNA expression of 
IL22RA was increased by IL-17 and decreased by IL-1β 
and TGF-β treatment (Fig. 2b, Additional file 6).
Comparing their IL19, IL20 and IL24 mRNA expres-
sions, significantly higher IL19 and IL24 expression was 
observed in the PBMCs of children with CD compared 
to controls (Fig. 2c–e). In PBMCs derived from patient 
with CD, IL-1β treatment increased, and TGF-β treat-
ment decreased the mRNA expression of IL19 and IL24. 
IL20 mRNA was not detectable either in the untreated 
or treated groups (Fig. 2f, Additional file 7).
Effect of IL‑24 treatment on the viability of  H2O2 treated 
FHs74Int cells
Decreased viability of  H2O2 treated FHs74Int cells was 
improved by IL-24 (Fig.  3a). Accordingly, LDH activ-
ity in the supernatant of  H2O2 treated cells was signifi-
cantly reduced by IL-24 (Fig. 3b), and IL-24 treatment 
reduced the number of apoptotic (Annexin V and PI 
positive) cells in the  H2O2 treated group from 61% to 
31% (Fig.  3c). IL-24 treatment decreased the  H2O2 
induced mRNA expression of IL1A, IL6 and TNF, as 
well (Fig. 3d, f, g).
Effect of IL‑24 treatment on the proliferation of pdMFs
We found that IL-24 treatment decreased the endog-
enous and also the PDGF-B induced proliferation of 
Fig. 2 Effect of IL‑1β, TNF‑α, TGF‑β and IL‑17 treatment on the expression of IL19, IL20, IL24 and their receptors. The mRNA expression of IL19, IL20, 
IL24, IL20RA, IL20RB and IL22RA was determined by real‑time RT‑PCR in comparison with RPLP0 as internal control. Heat maps illustrate the mean fold 
change in relative expression of the examined genes after different treatments in FHs74Int cells (a), pdMFs (b) and PBMCs of children with CD (f) 
compared to vehicle controls (n = 6). Graphs of individual measurements can be found in Additional files 3, 4, 5, 6, 7. The mRNA expression of IL19 
(c), IL20 (d) and IL24 (e) was determined in the PBMCs of 8–8 children with CD and controls, respectively. Results are presented as mean ± SD. ND: 
not detectable; *p < 0.05 vs. control (Mann–Whitney U‑test)
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Fig. 3 Effect of IL‑24 treatment on the viability of  H2O2 treated FHs74Int cells. The effect of IL‑24 on the viability of the  H2O2 treated cells was 
investigated by MTT (a), LDH (b) and Annexin V apoptosis (c) assays. Results of MTT and LDH assays (n = 5) are presented as the percentage of the 
untreated group (0 µM  H2O2 control), and as the percentage of total cells in the case of Annexin V apoptosis assay (n = 3 × 3 replicates). The mRNA 
expression of IL1A (d), IL1B (e), IL6 (f) and TNF (g) was determined by real‑time RT‑PCR in comparison with RPLP0 as internal control (n = 5). Results 
are presented as mean + SD. *p < 0.05 vs. 0 µM H2O2 control (two‑way ANOVA); #p < 0.05 vs. IL‑24 +0 µM H2O2 (two‑way ANOVA); §p < 0.05 control vs. 
IL‑24 at the concerning  H2O2 concentration (multiple t‑test); $p < 0.05 vs. control (two‑way ANOVA); 
€p < 0.05 vs.  H2O2 (two‑way ANOVA)
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pdMFs as suggested by the MTT assay (Fig.  4a). How-
ever IL-24 treatment did not affect the LDH release of 
the cells demonstrating that it did not affect the viability 
of PDGF-B treated pdMFs (Fig.  4b). Accordingly, IL-24 
treatment decreased the PDGF-B induced expression of 
proliferation markers, including PCNA and of KI67, but 
had no effect on the expression of the regulators of apop-
tosis including CDKN1A or TP53 (Fig. 4c–f).
Effect of IL‑24 treatment on the stress fiber orientation 
of pdMFs
Elongated morphology with highly parallel α-SMA 
immunopositive stress fibers were observed in untreated 
and TGF-β treated pdMFs. Orientation of the stress fiber 
system and cell morphology of pdMFs was significantly 
changed by IL-24, as the angles between the stress fib-
ers and the longitudinal axis of the cells increased, and 
circular fiber displacement and sheet-like cell shape 
were experienced after IL-24 treatment (Fig.  5a, b). 
Accordingly, IL-24 treatment increased the mRNA 
expression of ACTA2, ACTB, VIM, SNAI1 and SNAI2 as 
it was compared to the controls (Fig. 5c).
Discussion
The architecture of the small intestinal mucosa is main-
tained by a precisely controlled balance among entero-
cyte proliferation in the crypts, migration along the villi 
and shedding of the senescent epithelial cells at the tip 
of the villi into the intestinal lumen [24]. This fine-tuned 
process requires tight cooperation between enterocytes 
and the underlying subepithelial MFs [25]. In CD the 
chronic mucosal inflammation disturbs this fine-tuned 
process leading to villous atrophy and crypt hyperplasia.
In the present study we investigated the role of IL-19, 
IL-20 and IL-24 in mucosal remodeling in CD, which 
is indicated by the increased amount of MF marker 
α smooth muscle actin (α-SMA) and the extracellu-
lar matrix (ECM) component fibronectin (FN) in the 
Fig. 4 Effect of IL‑24 treatment on the proliferation of pdMFs. Cell proliferation and cytotoxicity was investigated by MTT (a) and LDH (b) assays 
(n = 5). Results are presented as the percentage of the untreated group (0 ng/mL IL‑24 control). The mRNA expression of PCNA (c), KI67 (d), CDKN1A 
(e), and TP53 (f) was determined by real‑time RT‑PCR (n = 5) in comparison with RPLP0 as internal control. Results are presented as mean + SD 
*p < 0.05 vs. 0 ng/mL IL‑24 control (two‑way ANOVA); #p < 0.05 vs. PDGF‑B +0 ng/mL IL‑24 (two‑way ANOVA)
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inflamed duodenal mucosa of children with CD (Fig. 1e–
g). Recently, the role of IL-20 cytokine subfamily has 
been proposed in tissue remodeling [26], and increased 
expression of IL-19, -20 and -24 was demonstrated in 
PBMCs and also in colonic mucosa of adult IBD patients 
[11, 13–15]. It has been suggested that these cytokines 
may protect the integrity of the inflamed mucosa of 
patients with IBD. However, to the best of our knowledge 
our study is the first one that investigated the role of the 
subfamily in the pathomechanism of CD.
Although the amount of IL-24 of the investigated chil-
dren showed no correlation with the clinical parameters 
(data not shown) we found increased mRNA expres-
sion and protein level of IL-24 in the duodenal mucosa 
of children with CD (Fig. 1c, d) IL-24 was present in the 
mucosal epithelial layer and also in the lamina propria 
of CD patients (Fig.  1i). Increased expression of IL19 
and IL24 was observed in PBMCs isolated from children 
with CD compared to those of healthy children, as well 
(Fig. 2c, e). Despite the common features of the investi-
gated cytokines of the IL-20 subfamily, IL20 was not even 
detectable in the duodenal mucosa or in PBMCs of chil-
dren with CD (Figs. 1b, 2d).
We also investigated the role of CD associated inflam-
matory cytokines and growth factors IL-1β, TNF-α, 
TGF-β and IL-17 on the expression of IL-19, -20 and 
-24 in FHs74Int duodenal epithelial cells (Fig. 2a; Addi-
tional file  3), pdMFs (Fig.  2b; Additional file  5) and in 
PBMCs derived from pediatric patient with CD (Fig. 2f; 
Additional file  7). Although, all factors influenced the 
Fig. 5 Effect of IL‑24 treatment on the stress fiber orientation of pdMFs. α‑SMA immunopositive stress fibers was visualized by immunofluorescence 
staining (green) (a). The orientation of stress fibers was assessed by graphical analysis (b) using ImageJ 1.48v software. Plots represent the width 
of 95% confidence intervals of the measured angels between stress fibers and the long axis of the investigated cell (n = 35–40). Horizontal lines 
indicate mean ± SD. Scale bar: 200 µm or 50 µm. Relative mRNA expression of ACTA2, ACTB, VIM, SNAI1 and SNAI2 (c) was determined by real‑time 
RT‑PCR (n = 5) in comparison with RPLP0 as internal control. Results are presented as mean + SD. *p < 0.05 vs. control (Kruskal–Wallis test), #p < 0.05 
vs. TGF‑β (Kruskal–Wallis test). $p < 0.05 vs. control (Mann–Whitney U‑test)
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production of the investigated cytokines, the effect of 
IL-1β was the most significant. Indeed, IL-1β treatment 
increased the expression of all three cytokines in each cell 
type, except IL20 expression in PBMCs, which remained 
undetectable. Our experiments may also explain the 
increased amount of IL-24 in the duodenal mucosa of 
children with CD, as the increase in IL24 expression 
after IL-1β stimulation was an order of magnitude higher 
in pdMFs than that of IL19 or IL20 (Additional file  5). 
Our results are in accordance with the observation of 
Andoh et al. [11], who suggested that IL-1β is the main 
inducer of IL-24 in subepithelial colon MFs. In contrast, 
they found that IL-1β treatment has no effect on the 
IL24 expression in HT-29, Caco-2 or SW480 colon epi-
thelial cells. However, this contradiction may be due to 
the different origin of the investigated cell lines. While 
FHs74Int cells originate from healthy small intestine, the 
cell lines investigated by Andoh et  al. are derived from 
different colorectal carcinomas.
However, in contrast to Andoh et al. we demonstrated 
that beside IL-1β other factors may also significantly 
influence the expression of IL19, IL20 or IL24. Indeed, we 
found that TNF-α also affect the expression of the inves-
tigated cytokines but in a cell type dependent manner. 
While TNF-α treatment increased the expression of IL19, 
IL20 and IL24 in the pdMFs it decreased their expres-
sion in the FHs74Int epithelial cells and had no effect 
in the PBMCs (Fig. 2). Previously, it has been described, 
that TNF-α has cell-type-specific effect on the regula-
tion of genes involved in inflammation, cell homeostasis, 
proliferation or viability [27]. Lee A. et  al. revealed that 
TNF-α treatment induce a remarkable and sustained 
IL-6 production of synovial fibroblasts, but not in mac-
rophages, where only a transient increase of IL-6 pro-
duction was observed. They demonstrated that TNF-α 
treatment increase the level of the well-known inhibi-
tors of cytokine expression, including ABIN3, IRAK-M, 
SOCS3 and ATF3 in the macrophages thus inhibiting the 
expression of IL-6. These factors are present not only in 
immune cells [28] but also in epithelial cells [29], there-
fore they may influence the IL-24 expression of the 
FHs74Int epithelial cells, as well.
Taken together, our results demonstrated that, epithe-
lial cells, MFs and PBMCs are responsible for IL-19, -20 
and -24 production in response to mucosal inflammation 
in CD.
Biological effects of IL-19, -20 and -24 are mediated by 
IL-20RA/IL-20RB or IL-22RA/IL-20RB receptor com-
plexes. We found that presence of the common IL-20RB 
subunit was increased on epithelial cells and on lamina 
propria cells of the duodenal mucosa of children with 
CD (Fig. 1i) and it was also expressed by FHs74Int cells 
and pdMFs (Fig. 1h). Our experiments also demonstrated 
that the expression of IL20RA, IL20RB and IL22RA 
receptor subunits is tightly regulated by the investigated 
inflammatory cytokines. Indeed, while most treatment, 
including IL-1β, TNF-α or TGF-β, increased the synthe-
sis of the IL20RB receptor subunit, the same treatments 
decreased the expression of IL20RA or IL22RA subunits 
in FHs74Int cells (Fig.  2a; Additional file  4) and pdMFs 
(Fig.  2b; Additional file  6). The decreased expression of 
IL20RA or IL22RA subunits might inhibit the forma-
tion of mature receptor complexes in the inflamed duo-
denal mucosa. However, it has recently been reported 
that IL-24 can bind to IL-20RB monomers as well [10]. 
This interaction then promotes the dimerization of IL-
20RB with IL-20RA and IL-22RA subunits, which further 
enhances the binding affinity of the receptor complexes 
to their ligands [30]. These data together with the 
increased mucosal expression of IL-24 suggest its unique 
importance amongst the investigated cytokines in the 
pathomechanism of CD.
Thus, the following in vitro experiments we focused on 
IL-24 to reveal its possible biological role in the patho-
mechanism of CD. The gluten exposure and the evolving 
chronic inflammation in CD lead to the overproduction 
of reactive oxygen species contributing to small intestinal 
epithelial damage [31]. Investigating the effect of IL-24 on 
oxidative stress related damage, we found that it exerts a 
protective effect in epithelial cells according to the results 
of our MTT, LDH or Annexin V assays (Fig. 3a–c). IL-24 
treatment also decreased the expression of IL1A, IL6 and 
TNF inflammatory cytokines in FHs74Int cells (Fig. 3d, f, 
g). This observation is in accordance with the literature 
demonstrating the anti-inflammatory effect of the IL-20 
subfamily members and also of the larger, IL-10 family 
of cytokines [4]. Taken together, our results suggest that 
IL-24 has beneficial effects on the preservation of epithe-
lial layer integrity in the inflamed duodenal mucosa.
The physiological or damage associated renewal of the 
intestinal epithelial layer highly depends on the integ-
rity of the underlying basement membrane composed of 
ECM proteins, like collagens, laminin and fibronectin. 
Components of the basement membrane are produced 
by subepithelial MFs of the small intestine [32, 33], there-
fore they play a key role in the regeneration of the coeliac 
mucosa.
Examining the role of IL-24 on pdMFs we experi-
enced that IL-24 significantly influences their morphol-
ogy. Whilst in untreated or TGF-β stimulated pdMFs the 
stress fibers, laid parallel with the longitudinal axis of the 
cells, we found circular fiber displacement and sheet-like 
shape of IL-24 treated pdMFs (Fig.  5a, b). Accordingly, 
IL-24 increased the expression of cytoskeletal structural 
components (α-SMA (encoded by ACTA2 gene) and 
ß-actin (ACTB), vimentin (VIM) and cell morphology 
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regulators (Snail (SNAI1) and Slug (SCNAI2)) (Fig.  5c), 
confirming its regulatory role on stress fiber organization.
Recently, Roncoroni et  al. demonstrated that simi-
larly to our IL-24 treated pdMFs, MFs isolated from 
CD patients are characterized by circular stress fiber 
orientation and sheet-like shape. These MFs also had 
decreased motility compared to elongated MFs iso-
lated from controls [24]. They suggested that decreased 
motility of sheet-like MFs may contributes to disease 
progression, as the reconstitution of normal epithelial 
structure may require the migration of MFs to the site of 
the injury. However, the connection between the orienta-
tion of stress fibers and disease progression may be more 
complex.
Previously, it has been demonstrated that actin-myosin 
filaments are the major determinant of traction force 
(TF) generated by the MFs and that the incorporation 
of α-SMA into the stress fibers significantly enhances 
the extent of TF [32–34]. It has been also shown that the 
generated TF is far greater than needed for cell migra-
tion, it is rather responsible for the contraction of the 
ECM by the MFs [35–37]. Moreover, subepithelial MFs 
are continuously present in healthy and inflamed duode-
nal mucosa, as well [38]. Therefore, we suggest that the 
observed effects of IL-24 on the expression of α-SMA 
and cell morphology may rather contribute to the genera-
tion of increased TF and contraction of the surrounding 
ECM [24].
The effect of IL-24 on proliferation rate and ECM 
production of pdMFs was also investigated. IL-24 treat-
ment significantly decreased endogenous and also the 
PDGF-B induced proliferation of pdMFs (Fig. 4a) with-
out affecting their viability (Fig.  4b). Accordingly, we 
found altered expression of cell cycle regulators in IL-24 
treated cells (PCNA, KI67, CDKN1A) (Fig.  4c–f ) [39, 
40]. Our findings are in accordance with the study of 
Liang et  al., demonstrating that IL-24 is a potent anti-
proliferative agent, as overexpression of IL-24 inhibits 
the proliferation of keloid fibroblasts [41]. The expres-
sion of COL1A1, which encodes collagen type I, the one 
of the main connective tissue component was slightly 
increased by IL-24 treatment, but it did not affect the 
overall ECM production of pdMFs (Additional file  8). 
Although MFs and ECM components play an essen-
tial role in tissue regeneration, their excessive prolif-
eration and ECM production leads to fibrosis and the 
destruction of the normal tissue architecture [26]. The 
observed effects of IL-24 on the proliferation and ECM 
production of pdMFs suggest its role in regenerative 
tissue remodeling contributing to the reconstitution of 
normal mucosal architecture in CD.
Conclusion
In summary although there are limitations of our study, 
including the number and origin of the human samples, 
which do not let us to compare the expression of the 
investigated cytokines between therapy naive children 
with CD and children with CD receiving GFD, we made 
great progress in the understanding of the biological 
effects of IL-24 in the pathomechanism of CD. We dem-
onstrated increased expression of IL-24 in the duodenal 
mucosa of therapy naive children with CD. We described 
the regulatory role of IL-1ß, TNF-α, TGF-β and IL-17 
on the IL-24 production of FHs74Int duodenal epithe-
lial cells, pdMFs and PBMCs. We showed that IL-24 can 
protect epithelial cells against oxidative damage, thus it 
may facilitate the maintenance of epithelial integrity. 
IL-24 inhibited the proliferation of pdMFs and altered 
their stress fiber organization, thereby suggesting its role 
in the reconstitution of normal epithelial structure and 
mucosal integrity. Currently, the only available therapy of 
CD is the GFD, which requires increased attention and 
makes the everyday life difficult, decreasing the compli-
ance of the patients [42]. Moreover, high number of the 
patients does not respond to the GFD. These unsolved 
difficulties necessitate the better understanding the path-
omechanism of the disease. We hope that our and other 
work suggesting the importance of inflammatory factors, 
including IL-15, IL-21, IL-24, or IFN-γ [43], may finally 
contribute to the identification of novel biomarkers and 
new drugs to treat CD.
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